Standard
Editorial : Percutaneous placement of a permanent tunnelled catheter for patients with non-malignant ascites—Is it safe? / Gluud, Lise Lotte; Kimer, Nina; Møller, Søren.
I:
Alimentary Pharmacology and Therapeutics, Bind 56, Nr. 5, 2022, s. 909-910.
Publikation: Bidrag til tidsskrift › Leder › Forskning › fagfællebedømt
Harvard
Gluud, LL, Kimer, N
& Møller, S 2022, '
Editorial: Percutaneous placement of a permanent tunnelled catheter for patients with non-malignant ascites—Is it safe?',
Alimentary Pharmacology and Therapeutics, bind 56, nr. 5, s. 909-910.
https://doi.org/10.1111/apt.17099
APA
Gluud, L. L., Kimer, N.
, & Møller, S. (2022).
Editorial: Percutaneous placement of a permanent tunnelled catheter for patients with non-malignant ascites—Is it safe? Alimentary Pharmacology and Therapeutics,
56(5), 909-910.
https://doi.org/10.1111/apt.17099
Vancouver
Gluud LL, Kimer N
, Møller S.
Editorial: Percutaneous placement of a permanent tunnelled catheter for patients with non-malignant ascites—Is it safe? Alimentary Pharmacology and Therapeutics. 2022;56(5):909-910.
https://doi.org/10.1111/apt.17099
Author
Gluud, Lise Lotte ; Kimer, Nina ; Møller, Søren. / Editorial : Percutaneous placement of a permanent tunnelled catheter for patients with non-malignant ascites—Is it safe?. I: Alimentary Pharmacology and Therapeutics. 2022 ; Bind 56, Nr. 5. s. 909-910.
Bibtex
@article{18b44c3b549442ea84e2821b2d1cdf44,
title = "Editorial: Percutaneous placement of a permanent tunnelled catheter for patients with non-malignant ascites—Is it safe?",
author = "Gluud, {Lise Lotte} and Nina Kimer and S{\o}ren M{\o}ller",
note = "Funding Information: Dr Gluud research funding from Novo Nordisk, Alexion, Gilead, Vingmed and honoraria as consultant/speaker/expert testimony from Novo Nordisk, Pfizer, Sobi International, and Norgine. Dr Kimer speaker, Norgine. Dr M{\o}ller, none declared. Declaration of personal interests: ",
year = "2022",
doi = "10.1111/apt.17099",
language = "English",
volume = "56",
pages = "909--910",
journal = "Alimentary Pharmacology and Therapeutics, Supplement",
issn = "0953-0673",
publisher = "Wiley-Blackwell",
number = "5",
}
RIS
TY - JOUR
T1 - Editorial
T2 - Percutaneous placement of a permanent tunnelled catheter for patients with non-malignant ascites—Is it safe?
AU - Gluud, Lise Lotte
AU - Kimer, Nina
AU - Møller, Søren
N1 - Funding Information:
Dr Gluud research funding from Novo Nordisk, Alexion, Gilead, Vingmed and honoraria as consultant/speaker/expert testimony from Novo Nordisk, Pfizer, Sobi International, and Norgine. Dr Kimer speaker, Norgine. Dr Møller, none declared. Declaration of personal interests:
PY - 2022
Y1 - 2022
U2 - 10.1111/apt.17099
DO - 10.1111/apt.17099
M3 - Editorial
C2 - 35934857
AN - SCOPUS:85135523192
VL - 56
SP - 909
EP - 910
JO - Alimentary Pharmacology and Therapeutics, Supplement
JF - Alimentary Pharmacology and Therapeutics, Supplement
SN - 0953-0673
IS - 5
ER -
